Dataset: FCHL-statin-treatment
Whole genome expression analysis of isolated human subcutaneous adipocytes from human subjects with Familial Combined Hyperlipidemia...
Whole genome expression analysis of isolated human subcutaneous adipocytes from human subjects with Familial Combined Hyperlipidemia (FCHL) prior to and after 8 weeks treatment with 40 mg atorvastatin
- Species:
- human
- Samples:
- 24
- Source:
- E-MTAB-758
- Updated:
- Dec.12, 2014
- Registered:
- Sep.22, 2014
Factors:
(via ArrayExpress)
Sample | COMPOUND | DOSE |
---|---|---|
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298524 | atorvastatin | 40 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |
SS298527 | No treatment | 0 |